These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 18995216

  • 1. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F, Rezori B, Neef M, Lammert F, Sauerbruch T, Spengler U, Reichel C.
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [Abstract] [Full Text] [Related]

  • 3. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 4. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK, Lee JS, Kim NH, Kim KA, Moon YS, Oh MK.
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [Abstract] [Full Text] [Related]

  • 5. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 6. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 7. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 8. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH, Park SH, Kim GW, Lee WJ, Hong WK, Ryu MS, Park KT, Lee MY, Lee CW, Kim JH, Kim YM, Kim SJ, Baik GH, Kim JB, Kim DJ.
    Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
    [Abstract] [Full Text] [Related]

  • 10. Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection.
    Khan R, Abid S, Jafri W, Awan S, Hamid S, Shah H, Pervez S.
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):694-8. PubMed ID: 19889264
    [Abstract] [Full Text] [Related]

  • 11. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P, Desai N, Alexander J, Singh DP, Sawant P.
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [Abstract] [Full Text] [Related]

  • 12. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [Abstract] [Full Text] [Related]

  • 13. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G.
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [Abstract] [Full Text] [Related]

  • 14. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY, Chuang WL, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Huang JF, Hsieh MY, Wang LY, Tsai JF, Wen-Yu, Yu ML.
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
    Chan HL, Chim AM, Lau JT, Hui AY, Wong VW, Sung JJ.
    Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555
    [Abstract] [Full Text] [Related]

  • 16. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N, Fagan SP, Berger DH, Awad SS.
    Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
    [Abstract] [Full Text] [Related]

  • 17. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS, Jiang JN.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [Abstract] [Full Text] [Related]

  • 18. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.
    Cholongitas E, Senzolo M, Patch D, Kwong K, Nikolopoulou V, Leandro G, Shaw S, Burroughs AK.
    Aliment Pharmacol Ther; 2006 Apr 01; 23(7):883-93. PubMed ID: 16573791
    [Abstract] [Full Text] [Related]

  • 19. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
    Antaki F, Lukowski A.
    J Clin Gastroenterol; 2007 Apr 01; 41(4):412-5. PubMed ID: 17413612
    [Abstract] [Full Text] [Related]

  • 20. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.
    Am J Gastroenterol; 2002 Nov 01; 97(11):2855-60. PubMed ID: 12425560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.